FITC Anti-Human CD56 (MEM 188)

CD56 Monoclonal Antibody for FC

Host / Isotype

Mouse / IgG2a

Reactivity

Human

Applications

FC

Conjugate

FITC Fluorescent Dye

CloneNo.

MEM 188

Cat no : FITC-65067

Synonyms

CD56, MSK39, N CAM 1, NCAM, NCAM 1, NCAM1

---

Validation Data Gallery

• 

  FC experiment of human peripheral blood lymphocytes using FITC-65067

  1X10^6 human peripheral blood lymphocytes were surface stained with 10 ul FITC-Anti-Human CD56 (FITC-65067, clone MEM 188) (red) or 10 ul FITC-mouse IgG2a isotype control (blue). Cells were not fixed.

---

Tested Applications

• Positive FC detected in: Human peripheral blood lymphocytes

Recommended dilution

Application	Dilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 10 µl per 10^6 cells in a 100 µl suspension or 10 µl per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

Product Information

FITC-65067 targets CD56 in FC applications and shows reactivity with Human samples.

• Tested Reactivity: Human
• Host / Isotype: Mouse / IgG2a
• Class: Monoclonal
• Type: Antibody
• Immunogen: Acute myelogenous leukemia cell line KG-1
• Full Name: neural cell adhesion molecule 1
• GenBank Accession Number: BC014205
• Gene Symbol: NCAM1
• Gene ID (NCBI): 4684
• RRID: AB_2883757
• Conjugate: FITC Fluorescent Dye
• Excitation/Emission Maxima Wavelengths: 494 nm / 520 nm
• Form: Liquid
• Purification Method: Affinity purification
• Storage Buffer: PBS with 0.1% sodium azide.
• Storage Conditions: Store at 2-8°C. Avoid exposure to light.

Background Information

Neural cell adhesion molecule 1 (NCAM1, also known as CD56) is a cell adhesion glycoprotein of the immunoglobulin (Ig) superfamily. It is a multifunction protein involved in synaptic plasticity, neurodevelopment, and neurogenesis. NCAM1 is expressed on human neurones, glial cells, skeletal muscle cells, NK cells and a subset of T cells, and the expression is observed in a wide variety human tumors, including myeloma, myeloid leukemia, neuroendocrine tumors, Wilms' tumor, neuroblastoma, and NK/T cell lymphomas.